Clinical Trials · NCT07653412
Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- National and Kapodistrian University of Athens
- Enrollment
- 220
- Start date
- Apr 2026
- Locations
- 1 site, Greece
- Primary endpoint
- Percentage weight loss at 6 months